Of the 30 people who developed blood clots after receiving the Oxford-AstraZeneca vaccine, seven died, UK regulators said on Saturday.
Deaths in the UK stems from the fact that some European countries no longer use the AstraZeneca vaccine due to possible blood clotting links. The UK’s drug and health products regulator said in a statement: “Of the 30 reports up to and including March 24, 7 have unfortunately died.”
On Friday, the Netherlands canceled vaccination with the AstraZeneca vaccine for anyone under 60 after five new cases in women, one of whom died. Germany made a similar decision earlier this week.
The European Medicines Agency (EMA), which like the World Health Organization (WHO) previously declared the AstraZeneca vaccine safe, is expected to announce its latest recommendations on the matter on April 7.
Wednesday’s EMA reiterated that they believe the vaccine is safe and that experts have not identified specific risk factors such as age, gender, or medical history. UK regulators say the 30 thrombosis reports submitted by medical professionals or the public via government websites came after 18.1 million doses of vaccine were administered in the country.
Most of the cases (22) were cerebral venous sinus thrombosis, a rare condition in which a blood clot forms in the brain.